Nimbolide inhibits tumor growth by restoring hepatic tight junction protein expression and reduced inflammation in an experimental hepatocarcinogenesis

doi:10.3748/wjg.v26.i45.7131

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 45

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9370)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-8) series, Tables (1-3) series.

Item

Count

PDF

483

WORD

230

HTML

3770

Figures (1-8)

491

Tables (1-3)

361

Sum=5335

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

391

Download

917

Sum=1308

Publishing Process of This Article

Item

Count

Browse

666

Download

2061

Sum=2727

Dec 7, 2020 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Dec 7, 2020; 26(45): 7131-7152
Published online Dec 7, 2020. doi: 10.3748/wjg.v26.i45.7131

Table 1 Mean tumor volume and tumor growth inhibition (%) in the experimental mice

Experimental groups	Mean tumor volume (mm³)	Tumor growth inhibition (%)
HCC	78.45 ± 11.87	-
HCC + nimbolide	37.60 ± 5.26^e	52.08
HCC + doxorubicin	35.73 ± 8.09^e	54.45

^eP < 0.01. HCC: Hepatocellular carcinoma.

Citation: Ram AK, Vairappan B, Srinivas BH. Nimbolide inhibits tumor growth by restoring hepatic tight junction protein expression and reduced inflammation in an experimental hepatocarcinogenesis. World J Gastroenterol 2020; 26(45): 7131-7152
URL: https://www.wjgnet.com/1007-9327/full/v26/i45/7131.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i45.7131